The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

Cardinal Health Inc

NYSE: CAH
Last

(U.S.) $87.99

Today's change-0.18 -0.20%
Updated February 27 4:05 PM EST. Delayed by at least 15 minutes.
 

Cardinal Health Inc

NYSE: CAH
Last

(U.S.) $87.99

Today's change-0.18 -0.20%
Updated February 27 4:05 PM EST. Delayed by at least 15 minutes.

Cardinal Health Inc down (U.S.)$0.18

Cardinal Health Inc closed lower Friday, dropping (U.S.)$0.18 or 0.20% to (U.S.)$87.99. Over the last five days, shares have gained 1.07% and are currently 1.61% off of the 52-week high. Shares have outperformed the S&P 500 by 9.00% during the last year.

Key company metrics

  • Open(U.S.) $88.06
  • Previous close(U.S.) $88.17
  • High(U.S.) $88.75
  • Low(U.S.) $87.89
  • Bid / Ask-- / --
  • YTD % change+8.99%
  • Volume1,502,298
  • Average volume (10-day)1,498,573
  • Average volume (1-month)2,001,756
  • Average volume (3-month)1,712,597
  • 52-week range(U.S.) $63.06 to (U.S.) $89.43
  • Beta0.54
  • Trailing P/E27.14×
  • P/E 1 year forward20.28×
  • Forward PEG1.61×
  • Indicated annual dividend(U.S.) $1.37
  • Dividend yield1.56%
  • Trailing EPS(U.S.) $3.24
Updated February 27 4:05 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+1.18%

Based on its net profit margin of 1.18%, Cardinal Health Inc is less effective than other companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.04%Sector:Non-Cyclical Consumer Goods & ServicesIndustry:Retail - Drugs
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2015Q1/2015Q4/2014Q3/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201412/31/2014Sep 30, 201409/30/2014Jun 30, 201406/30/2014Mar 31, 201403/31/2014
Revenue25,53724,07022,89421,427
Total other revenue--------
Total revenue25,53724,07022,89421,427
Gross profit1,4541,3411,2561,297
Total cost of revenue24,08322,72921,63820,130
Total operating expense25,05123,60422,50720,919
Selling / general / administrative815775779699
Research & development--------
Depreciation / amortization60536356
Interest expense (income), net operating--------
Unusual expense (income)93472734
Other operating expenses, total--------
Operating income486466387508
Interest income (expense), net non-operating-36-34-33-34
Gain (loss) on sale of assets--------
Other--------
Income before tax451435357507
Income after tax289266234315
Income tax, total162169123192
Net income289266234315
Total adjustments to net income--------
Net income before extra. items289266234315
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items289266234315
Inc. avail. to common incl. extra. items289266234315
Diluted net income289266234316
Dilution adjustment------1
Diluted weighted average shares334340342347
Diluted EPS excluding extraordinary itemsvalue per share0.870.780.680.91
Dividends per sharevalue per share0.340.340.350.30
Diluted normalized EPSvalue per share1.040.870.740.97